Bækdal, Tine A.
Novo Nordisk (Denmark)
7 papers on CoChatORCID 0000-0002-1348-0352
Most cited papers
- Verified
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine
Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems
Cited by 553
- Verified
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
Granhall, C., Donsmark, M., Blicher, T. M., Golor, G., Søndergaard, F. L., Thomsen, M., & Bækdal, T. A. (2019) · Clinical Pharmacokinetics
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 190
- Verified
Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes
Gibbons, C., Blundell, J., Tetens Hoff, S., Dahl, K., Bauer, R., & Bækdal, T. (2021) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementRegulation of Appetite and Obesity
Cited by 149
- Verified
Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat‐rich meal in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, cross‐over trial
Hermansen, K., Bækdal, T. A., Düring, M., Pietraszek, A., Mortensen, L. S., Jørgensen, H., & Flint, A. (2013) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 143
- Verified
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes
Dahl, K., Brooks, A., Almazedi, F., Hoff, S. T., Boschini, C., & Bækdal, T. A. (2021) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 87
- Verified
The effect of escitalopram on sleep problems in depressed patients
Lader, M., Andersen, H. F., & Bækdal, T. (2005) · Human Psychopharmacology: Clinical and Experimental
Treatment of Major DepressionSleep and related disorders
Cited by 34
- Verified
Author response for "Response to the letter from Horowitz et al to the Editor relating to the publication ‘Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes’ by Dahl et al"
Dahl, K., & Bækdal, T. A. (2021) · Publons reviews and discussion
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free